Hikari Tsushin Inc. Buys 2,470 Shares of Express Scripts Holding Co (ESRX)

Hikari Tsushin Inc. grew its stake in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 13.7% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 20,470 shares of the company’s stock after buying an additional 2,470 shares during the period. Express Scripts accounts for 0.4% of Hikari Tsushin Inc.’s investment portfolio, making the stock its 28th biggest position. Hikari Tsushin Inc.’s holdings in Express Scripts were worth $1,414,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently added to or reduced their stakes in the business. Bank of New York Mellon Corp increased its position in Express Scripts by 8.7% during the fourth quarter. Bank of New York Mellon Corp now owns 8,287,905 shares of the company’s stock worth $618,609,000 after buying an additional 666,754 shares in the last quarter. Massachusetts Financial Services Co. MA grew its position in shares of Express Scripts by 5.7% in the first quarter. Massachusetts Financial Services Co. MA now owns 7,190,246 shares of the company’s stock valued at $496,703,000 after purchasing an additional 388,601 shares during the period. Geode Capital Management LLC grew its position in shares of Express Scripts by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 6,608,383 shares of the company’s stock valued at $492,297,000 after purchasing an additional 32,548 shares during the period. LSV Asset Management grew its position in shares of Express Scripts by 3.4% in the first quarter. LSV Asset Management now owns 5,090,166 shares of the company’s stock valued at $351,628,000 after purchasing an additional 165,700 shares during the period. Finally, Pzena Investment Management LLC grew its position in shares of Express Scripts by 2.6% in the fourth quarter. Pzena Investment Management LLC now owns 3,602,780 shares of the company’s stock valued at $268,911,000 after purchasing an additional 92,980 shares during the period. 85.70% of the stock is owned by institutional investors.

A number of brokerages have recently commented on ESRX. BidaskClub downgraded Express Scripts from a “buy” rating to a “hold” rating in a research report on Thursday, June 7th. William Blair downgraded Express Scripts from an “outperform” rating to a “market perform” rating in a research report on Thursday, March 8th. Barclays lowered their price objective on Express Scripts from $84.00 to $83.00 and set an “equal weight” rating for the company in a research report on Thursday, May 3rd. Robert W. Baird set a $92.00 price objective on Express Scripts and gave the company a “buy” rating in a research report on Thursday, May 17th. Finally, ValuEngine downgraded Express Scripts from a “buy” rating to a “hold” rating in a research report on Wednesday, May 2nd. Four investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and five have assigned a buy rating to the company. Express Scripts presently has an average rating of “Hold” and a consensus price target of $82.46.

Express Scripts stock traded down $0.18 during midday trading on Thursday, reaching $81.59. The stock had a trading volume of 18,388 shares, compared to its average volume of 4,551,790. Express Scripts Holding Co has a twelve month low of $55.80 and a twelve month high of $85.07. The stock has a market capitalization of $44.70 billion, a P/E ratio of 11.48, a PEG ratio of 1.00 and a beta of 0.96. The company has a current ratio of 0.69, a quick ratio of 0.56 and a debt-to-equity ratio of 0.81.

Express Scripts (NASDAQ:ESRX) last issued its earnings results on Wednesday, May 2nd. The company reported $1.77 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.76 by $0.01. Express Scripts had a return on equity of 25.41% and a net margin of 4.59%. The firm had revenue of $24.77 billion for the quarter, compared to analysts’ expectations of $24.80 billion. During the same quarter last year, the firm earned $1.33 earnings per share. The firm’s revenue for the quarter was up .5% compared to the same quarter last year. sell-side analysts predict that Express Scripts Holding Co will post 9.07 EPS for the current year.

Express Scripts Profile

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit